Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.
about
Interferon gamma effect on immune mediator production in human nerve cells infected by two strains of Toxoplasma gondiiImmune response and immunopathology during toxoplasmosisDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Passage of parasites across the blood-brain barrierTryptophan Catabolism in Chronic Viral Infections: Handling Uninvited GuestsIdentification of the microsporidian Encephalitozoon cuniculi as a new target of the IFNγ-inducible IRG resistance systemTH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism?Eating at the table of another: metabolomics of host-parasite interactions.Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infectionsInterferon-inducible effector mechanisms in cell-autonomous immunity.Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.The role of indoleamine 2,3 dioxygenase in beneficial effects of stem cells in hind limb ischemia reperfusion injury.Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.Inhibition of experimental asthma by indoleamine 2,3-dioxygenaseMechanisms of Toxoplasma gondii persistence and latency.Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral responseThe potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth.Latent toxoplasmosis and humanSystems analysis of host-parasite interactions.A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalenceCD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteinsRole of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.Mechanisms of microbial traversal of the blood-brain barrier.Direct Effect of Two Naphthalene-Sulfonyl-Indole Compounds on Toxoplasma gondii TachyzoiteManipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.How can microbial interactions with the blood-brain barrier modulate astroglial and neuronal function?Feast or famine: the host-pathogen battle over amino acids.The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects.Protein Malnutrition Alters Tryptophan and Angiotensin-Converting Enzyme 2 Homeostasis and Adaptive Immune Responses in Human Rotavirus-Infected Gnotobiotic Pigs with Human Infant Fecal Microbiota Transplant.Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities.Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses.The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes.Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
P2860
Q22807418-3F96D3DF-5CFD-45BA-8BF1-E2319081F8F9Q24612341-8F5F02EC-0F06-4AD5-B1E2-BC36199B6EDDQ24631189-67E5034B-FF9C-4365-AC10-8D192F6AC306Q24632132-266AC48C-0904-44F0-A965-4223F796613AQ26797214-4C1FEDB3-8610-446B-B2B8-EB1C9A1965ADQ27323191-32C4AD08-7A0B-4EC0-AC2B-F2B3330AC347Q27693193-28D9C8F4-B8DB-403B-8B1D-A4CF70868623Q33671828-2A76EC94-0FEE-490E-BB3F-261B1ACEEE69Q33951938-939263C6-BBE5-4A7C-BAF6-03849CC06EFBQ34114819-1F7D56E0-B6A6-459E-BCF8-E88BAC276004Q34364948-7DDD92BD-6F26-4AA2-83F2-50802A51198AQ34485130-D9FDACF0-80D3-457F-B3F0-F6626F6B15B2Q35154150-CA109537-8AEB-4D44-A489-A082060F627BQ35261125-29E3B743-5043-43E0-8C04-5FB911676FF6Q35804259-624B3C50-4325-433B-A03B-D3B289A45C35Q35835456-E87363E6-8906-49E2-90C1-E8F2F2E20DE0Q35870650-46288427-4C2E-4C90-90CA-0E19235B18FCQ36098825-5A8C1EB5-23FD-454B-B533-6FD103B2AD16Q36117580-66915831-526C-40B3-A482-26CBBFB2FDBFQ36370599-D14D30A3-28A9-481A-A65C-C92432F699C3Q36372378-C9F6DAEA-F45F-4583-810A-816F0652F30DQ36853287-D472AF8F-40A6-4498-A738-9874722947CDQ36911388-BC96B253-5310-40D5-91FC-2D8B3A03A7A4Q36954185-B38D940C-0212-40D4-8FBC-9FA003C40662Q37208293-CFE1CD58-6547-4632-BAA6-E526A8947B7FQ37283682-01F03661-E805-438B-9E42-921884DAE353Q37522460-150CC075-44F3-4BFF-8C68-7660F836E962Q37913497-8F06938C-84BF-4BB7-B2C8-2CDD4D7B76F4Q38092233-541FEE58-B5C1-4C36-9B8D-C96414EBA7B9Q39825479-DD9449A7-2936-4A4E-B917-062CE770B46AQ40163187-9AAABF0F-5FC4-405B-9852-BDE6B6E37B3DQ42010792-0AADA70B-114B-4D78-8D91-4B896A8520BEQ44134414-78547E86-821B-4152-BB82-F9694CB67BC3Q44445269-E07B8F47-E015-4CA9-8E6C-8759FDB6C8E7Q46790380-2E18ACC0-5533-48C0-A388-3C02560FC535Q54372448-44519D45-35A9-4FD9-8774-A75B180D1E02Q55333337-413CAB97-02F8-4AA4-B848-07BE5EB33C24
P2860
Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@ast
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@en
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@nl
type
label
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@ast
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@en
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@nl
prefLabel
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@ast
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@en
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@nl
P2093
P2860
P1476
Restriction of Toxoplasma gond ...... f indoleamine 2,3-dioxygenase.
@en
P2093
Däubener W
Schroten H
P2860
P304
P356
10.1128/IAI.69.10.6527-6531.2001
P407
P577
2001-10-01T00:00:00Z